Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Beacon Equity Research Featured Company: Cornerstone Therapeutics, Inc. (CRTX)

Cornerstone Therapeutics, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for the respiratory market in the United States. The company is dedicated to making quality medicines in order to improve the quality of life.

Cornerstone offers trusted medications such as Zyflo CR®, Spectracef® and AlleRx®. Zyflo CR® is an extended release oral medication that is used to prevent and treat asthma in adults and children 12 years and older. Infections caused by bacteria can be treated with Spectracef®, while those suffering from allergies will find relief by taking AlleRx®.

Cornerstone has successfully alienated themselves from their competitors by partnering with leading domestic and international pharmaceutical companies. Through strategic planning, the company aims to maximize the potential value and competitive position of its currently marketed products, newly acquired products and product candidates that are currently in development.

Let us hear your thoughts: Cornerstone Therapeutics, Inc. Message Board

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *